Carbapenem-resistant Acinetobacter baumannii infections after organ transplantation: Short communication

Transplant Infectious Disease

Volumn 12, Issue 1, 2010, Pages 87-93

  Reddy, P ^a   Zembower, T R ^a   Ison, M G ^a   Baker, T A ^a   Stosor, V ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Acinetobacter; Complications; Infections; Organ transplantation

Indexed keywords

AMIKACIN; COLISTIN; DOXYCYCLINE; FLUCONAZOLE; METHYLPREDNISOLONE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TIGECYCLINE; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; AGED; ARTICLE; CANDIDA; CANDIDIASIS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; KLEBSIELLA PNEUMONIAE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NONHUMAN; OUTCOME ASSESSMENT; PERITONITIS; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; URINARY TRACT INFECTION; UROSEPSIS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION;

EID: 77149146514     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2009.00445.x     Document Type: Article

References (29)

1. Kutinova A, Woodward RS, Ricci JF, Brennan DC. The incidence and cost of sepsis and pneumonia before and after renal transplantation in the United States. Am J Transplant 2006 6 : 129 139.
2. Linares L, Cervera C, Cofan F, et al. Epidemiology and outcomes of multiple antibiotic-resistant bacterial infection in renal transplantation. Transplant Proc 2007 39 : 2222 2224.
3. Singh N, Wagener MM, Obman A, Cacciarelli TV, de Vera ME, Gayowski T. Bacteremia in liver transplant recipients: shift towards gram-negative bacteria as predominant pathogens. Liver Transpl 2004 10 (7) : 844 849.
4. Abbo A, Navon-Venezia S, Hammer-Muntz O, Krichali T, Siegman-Igra Y, Carmeli Y. Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis 2005 11 : 22 29.
5. Sunenshine RH, Wright MO, Maragakis LL, et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 2007 13 (1) : 97 103.
6. Wareham DW, Bean DC, Khanna P, et al. Bloodstream infections due to Acinetobacter spp: epidemiology, risk factors, and impact of multi-drug resistance. Eur J Clin Microbiol Infect Dis 2008 27 (7) : 607 612.
7. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement. Vol. 25 (1) 2005.
8. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988 16 : 128 140.
9. Lolans K, Rice TW, Munoz-Price LS, Quinn JP. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the cabapenemase OXA-40. Antimicrob Agents Chemother 2006 50 (9) : 2941 2945.
10. Scheetz MH, Reddy P, Nicolau DP, et al. Peritoneal fluid penetration of tigecycline. Ann Pharmacother 2006 40 : 2064 2067.
11. Baran G, Erbay A, Bodur H, et al. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections. Intern J Infect Dis 2008 12 : 16 21.
12. Playford EG, Craig JC, Iredell JR. Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J Hosp Infect 2007 65 : 204 211.
13. Kuo LC, Lai CC, Liao CH, et al. Multidrug-resistant Acinetobacter baumannii bacteremia: clinical features, antimicrobial therapy and outcome. Clin Microbiol Infect 2007 13 (2) : 196 198.
14. Singh N, Gayowski T, Rihs JD, Wagener MM, Marino IR. Evolving trends in multiple antibiotic-resistant bacteria in liver transplant recipients: a longitudinal study of antimicrobial susceptibility patterns. Liver Transplant 2001 7 (1) : 22 26.
15. Trottier V, Namias N, Pust DG, et al. Outcomes of Acinetobacter baumannii infection in critically ill surgical patients. Surg Infect (Larchmt) 2007 8 (4) : 437 443. (Pubitemid 47493521)
16. Sopirala MM, Pope-Harman A, Nunley DR, Moffatt-Bruce S, Ross P, Martin SI. Multidrug resistant Acinetobacter baumannii pneumonia in lung transplant recipients. J Heart Lung Transplant 2008 27 (7) : 804 807.
17. del Mar Tomas M, Cartelle M, Pertega S, et al. Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk factors for colonization and infection. Clin Microbiol Infect 2005 11 : 540 546.
18. Kim YA, Choi JY, Kim CK, et al. Risk factors and outcomes of bloodstream infections with metallo-β-lactamase-producing Actinetobacter. Scand J Infect Dis 2008 40 : 234 240.
19. Surasarang K, Narksawat K, Danchaivijitr S, et al. Risk factors for multi-drug resistant Acinetobacter baumannii nosocomial infection. J Med Assoc Thai 2007 90 (8) : 1633 1639.
20. Gearhart M, Martin J, Rudich S, et al. Consequences of vancomycin-resistant Enterococcus in liver transplant recipients: a matched control study. Clin Transplant 2005 19 : 711 716.
21. Papanicolaou GA, Meyers BR, Meyers J, et al. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis 1996 23 (4) : 760 766.
22. Linares L, Cervera C, Cofan F, et al. Risk factors for infection with extended spectrum and AmpC-B-lactamase-producing gram-negative rods in renal transplantation. Am J Transplant 2008 8 : 1000 1005.
23. Malek SK, Obmann MA, Gotoff RA, Foltzer MA, Hartle JE, Potdar S. Campath-1H induction and the incidence of infectious complications in adult renal transplantation. Transplantation 2006 81 : 17 20.
24. Wood GC, Hanes SD, Croce MA, Fabian TC, Boucher BA. Comparison of ampicillin-sulbactam and imipenem-cilastin for the treatment of Acinetobacter ventilator-associated pneumonia. Clin Infect Dis 2002 34 (11) : 1425 1430.
25. Jellison TK, McKinnon PS, Rybak MJ. Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastin or ampicillin-sulbactam. Pharmacotherapy 2001 21 : 142 148.
26. Kasiakou SK, Michalopoulos A, Soteriades ES, Samonis G, Sermaides GJ, Falagas ME. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis. Antimicrob Agents Chemother 2005 49 : 3136 3146.
27. Petrosillo N, Chinello P, Proietti MF, et al. Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events. Clin Microbiol Infect 2005 11 : 682 683.
28. Taccone FS, Rodriguez-Villalobos H, De Backer D, et al. Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline. Eur J Clin Microbiol Infect Dis 2006 25 : 257 260.
29. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2007 51 (10) : 3471 3484.